While MS is still considered rare in India, we’re now seeing a shift toward moderate prevalence,” Dr M V Padma told Business ...

Roche Holdings AG (OTC:RHHBY) on Friday announced new 96-week data for fenebrutinib demonstrating that patients with ...

Scientists at the University Medical Center Hamburg-Eppendorf (UKE) and Heidelberg University Hospital (UKHD) have ...

Although rarely used in the US, it may be time to revisit HRT for women with MS, as it eases overlapping symptoms and offers ...

Dr Conor Kerley–who has the disease himself– says there are several theories as to why the small island has such a ...

Roche has shared positive new 96-week data for its investigational fenebrutinib in patients with relapsing forms of multiple ...

Roche presented promising 96-week data from the Phase II FENopta study, showing that its investigational drug, fenebrutinib, significantly reduce ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

The NHS has warned about potential symptoms of an incurable condition that profoundly affects the central nervous system.

Multiple Sclerosis cases are rising in India, especially among women, with experts stressing early diagnosis, access to ...

Multiple sclerosis MS a chronic neurological condition is an autoimmune disorder Scroll down to learn how to identify the ...